Rosen Law Firm is urging MoonLake Immunotherapeutics (NASDAQ: MLTX) shareholders with large losses to contact them about their investor rights. The announcement highlights the importance of seeking guidance if investors believe they have incurred significant damages.

MoonLake Immunotherapeutics (NASDAQ: MLTX) is under investigation by the DJS Law Group for possible securities fraud. The October 6, 2025, announcement has raised concerns among investors about potential violations of federal securities laws.